Xenofon Baraliakos was born in 1975 in Athens, Greece. From 1994 to 2000, he studies human medicine in Magdeburg and Berlin, Germany. He received a Ph.D. degree in 2005 with a thesis entitled “MRI examinations of the spine in patients with ankylosing spondylitis before and after therapy with the monoclonal anti-TNF-a antibody infliximab.” Since 2003, he has been a Researcher at Rheumazentrum Ruhrgebiet in Herne, Germany, in the field of spondyloarthritides. Since 2007, he has specialized in rheumatology and internal medicine at Rheumazentrum Ruhrgebiet in Herne, Germany. His research interests include clinical and academic research in the field of spondyloarthritides, with special emphasis on imaging outcomes and treatment of the disease. He won the Rheumatology Research Award, Glasgow, Scotland (2005), EULAR Young Investigator Award, Amsterdam, The Netherlands (2006), Abstract Award, German Congress of Rheumatology, Hamburg, Germany (2007), Abstract Award, Austrian Congress of Rheumatology, Vienna, Austria (2007), EULAR Young Investigator Award, Paris, France (2008), Research Award, German patient´s AS Society, Cologne, Germany (2010), Pfizer Research Award (2010), and Pfizer Research Award (2011). Moreover, he is a Member of the German Society of Rheumatology (DGRh), American College of Rheumatology (ACR), Ankylosing Spondylitis International Society (ASAS), Orthopaedic Society of South Germany (DSVO), Arthroscopy Society for German Speaking Countries (AGA), German Society of Accupuncture, German Society of Chiropractic, and Greek Society of Sports Medicine.
Biography Updated on 4 March 2012